Behavioral intervention to improve PrEP adherence for women with substance use disorders
Official title: Development and Pilot Testing of an Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders
Run by The University of Texas Health Science Center, Houston · NCT06158607 · Data updated 2026-11-12
This study is testing a new support program to help Black and Hispanic women with substance use issues take their PrEP medication more regularly and effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | June 7, 2022 |
| Main results expected | May 30, 2025 |
| Study ends | May 30, 2025 |
| Registry record updated | December 30, 2024 |
| Trial ID | NCT06158607 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Black/African American and Hispanic/Latina cisgender women who are HIV negative, diagnosed with a substance use disorder, and sexually active with an opposite sex partner.
✕Probably not a fit
Patients who are currently participating in another substance use disorder treatment program or are ineligible for PrEP based on CDC criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate a behavioral intervention designed to enhance the uptake and adherence of Pre-Exposure Prophylaxis (PrEP) among Black/African American and Hispanic/Latina women with substance use disorders. Participants will receive four counseling sessions, prevention navigation, and nurse practitioner-prescribed PrEP within an addiction treatment setting. The study will compare the effectiveness of this integrated intervention against standard treatment to determine its impact on PrEP adherence and uptake.
Why it matters
Potential benefit: If successful, this intervention could significantly improve HIV prevention among women with substance use disorders.
How similar studies have gone: While there have been studies focusing on PrEP adherence, this specific integrated intervention approach targeting women with substance use disorders is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Black/African American and Hispanic/Latina cisgender women * diagnosed with a Substance use disorder (SUD) per Diagnostic and Statistical Manual of Mental Illnesses (DSM)-5 criteria * HIV negative * sexually active with an opposite sex partner within the past 6 months * not using PrEP for HIV prevention at the time of screening * able to speak, read, and write in English; and * own or have regular access to a smart phone. Exclusion Criteria: * be concurrently participating in another SUD behavioral treatment program * unable to provide informed consent for participation (e.g., have severe cognitive impairment that would interfere with their ability to consent, understand study procedures and/or effectively participate in therapy * have psychological distress that would prohibit them from participating in the study * be unable or unwilling to meet study requirements * be ineligible for PrEP based on Centers for Disease Control and Prevention (CDC)-defined criteria for PrEP based on substance use and sexual risk * have medical contraindications for PrEP (e.g., known renal impairment which can be exacerbated by PrEP use).
Where it's running
-
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Angela Heads, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Angela Heads, PhD
- Email: Angela.M.Heads@uth.tmc.edu
- Phone: (713) 486-2830
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
iPAWS: Helping teens manage pain and risky behaviors after wisdom tooth removal
This program tests a short online intervention to help teens and their parents handle post-surgical pain and reduce risky behaviors after wisdom tooth extraction.
-
Returning to the Land intervention for families in a tribal community
This program tests a biodiverse outdoor intervention with a tribal community to help reduce caregiver substance use and support emotional/behavioral development in children ages 1–5, by engaging families where teens 14–19 participate.
-
Connecting incarcerated adults with virtual peer recovery coaches to support addiction care
This trial tests whether a virtual peer recovery coach program helps people in jail link to and stick with addiction treatment compared to standard care.
-
Screening and brief counseling for substance use in adult survivors of childhood cancer
This study tests whether a short, evidence-based substance-use screening plus a brief counseling session can be added into routine survivorship care for adult survivors of childhood cancer at St. Jude.
-
Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok
This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.
-
Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok
This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.